Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Merck & Co (NY:MRK)

100.30 +1.29 (+1.30%)
Official Closing Price Updated: 7:00 PM EST, Dec 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
3 Non-AI Stocks to Buy: MRK, UPS, CVX ↗
There are plenty of potential winners outside the world of AI. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Should You Buy This Blue Chip Pharmaceutical Stock That Just Popped 3.8%? ↗
The struggling pharmaceutical giant is showing signs of life. 
Via The Motley Fool
News headline image
Dow Industrials Erase November Losses: A Beacon of Optimism Amidst Market Crossroads
The Dow Jones Industrial Average (DJIA) has staged a remarkable comeback, successfully erasing its November 2025 losses by the month's final trading day, Friday, November 28, 2025. This significant... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Big Pharma Layoff Wave Extends Into Next Year: UNH, Merck, BMS, Novartis File New WARN Notices ↗
Via Stocktwits
Topics Workforce
Merck Says Its Two-Drug Regimen For HIV Treatment Proven Non-Inferior To Gilead’s Biktarvy In Study ↗
Via Stocktwits
News headline image
Merck & Co. Inc. (NYSE:MRK): A Dividend Stock with Strong Profitability and Financial Health ↗
Discover Merck (MRK), a top dividend stock with a 3.58% yield, strong growth history, and excellent profitability for reliable income. 
Via Chartmill
News headline image
Merck to Participate in the Citi 2025 Global Healthcare Conference
From Merck & Co., Inc.
Via Business Wire
News headline image
Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference
From Merck Sharp & Dohme
Via Business Wire
News headline image
Dow Jones Navigates Volatility Amidst AI Bubble Fears and Shifting Fed Expectations
The Dow Jones Industrial Average has been on a roller-coaster ride in November 2025, experiencing significant volatility and sending mixed signals across various sectors. While the index achieved a... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Stocks making big moves yesterday: Meta, Tenet Healthcare, Wynn Resorts, Elevance Health, and Merck
Check out the companies making headlines yesterday: 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Merck (MRK) Stock Is Trading Up Today
Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 4.1% in the afternoon session after Wells Fargo upgraded the stock to "Overweight" from "Equal-Weight," citing confidence in the... 
Via StockStory
Topics Artificial Intelligence Economy
Biotech Valuations Rise as New Clinical Platforms Show Progress
Via Investor Brand Network
News headline image
Biotech Valuations Rise as New Clinical Platforms Show Progress
From BioMedWire
Via GlobeNewswire
News headline image
Merck Data to be Presented at ASH 2025 Annual Meeting Showcase Continued Advancements in Hematology Pipeline and Novel Therapeutic Approaches
From Merck & Co., Inc.
Via Business Wire
News headline image
Q3 Earnings Outperformers: Merck (NYSE:MRK) And The Rest Of The Branded Pharmaceuticals Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Merck (NYSE:MRK) and the best and worst... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Merck Recommends Rejection of Tutanota’s “Mini-Tender” Offer
From Merck & Co., Inc.
Via Business Wire
News headline image
Mettler-Toledo, Agilent, Waters Corporation, Merck, and Regeneron Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy World Trade
News headline image
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), as Perioperative Treatment for Adults with Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
From Merck & Co., Inc.
Via Business Wire
News headline image
Goldman Sachs Just Delivered Bad News for U.S. Investors ... Sort Of. Here's What You Need to Know. ↗
The investment bank's analysts simply recognize how much has changed in just the past few years, and what that means for the near future. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs? ↗
The pharmaceutical giant's post-Keytruda plans continue to take shape. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know. ↗
Shares in the biotech company have surged on news of a big pharma takeover. 
Via The Motley Fool
News headline image
HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗
Via MarketBeat
News headline image
Merck's Investigational Two-Drug Regime Matches Gilead's Three-Drug Tablet For HIV Treatment ↗
Merck's HIV pill met key efficacy and safety goals in Phase 3 trials, matching Biktarvy as the FDA reviews its application with a 2026 decision date. 
Via Benzinga
News headline image
2 Healthcare Stocks Worth Your Attention and 1 We Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
News headline image
Why GRAIL Stock Could Be Biotech’s Next Big Breakout ↗
Via MarketBeat
News headline image
Healthcare Rotation Underway: 3 Stocks Leading the Charge ↗
Via MarketBeat
News headline image
Merck Announces Positive Topline Results from the Pivotal Phase 3 Trial Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) in Treatment-Naïve Adults with HIV-1 Infection
From Merck & Co., Inc.
Via Business Wire
News headline image
European Commission Approves Subcutaneous Administration of KEYTRUDA® (pembrolizumab) for All Adult Indications Approved in the European Union
From Merck & Co., Inc.
Via Business Wire
News headline image
Healthcare Sector Navigates Volatile Markets: A Defensive Anchor or Driven by Innovation?
As broader markets grapple with persistent volatility on November 18, 2025, the healthcare sector within the S&P 500 (SPX) finds itself under intense scrutiny. Traditionally viewed as a stalwart... 
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Which S&P500 stocks are moving on Tuesday? ↗
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.